Metabolomic and elemental profiling of human tissue in kidney cancer
Open Access
- 4 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Metabolomics
- Vol. 17 (3), 1-15
- https://doi.org/10.1007/s11306-021-01779-2
Abstract
Introduction: Kidney cancer is one of the most frequently diagnosed and the most lethal urinary cancer. Despite advances in treatment, no specific biomarker is currently in use to guide therapeutic interventions. Objectives: Major aim of this work was to perform metabolomic and elemental profiling of human kidney cancer and normal tissue and to evaluate cancer biomarkers. Methods: Metabolic and elemental profiling of tumor and adjacent normal human kidney tissue from 50 patients with kidney cancer was undertaken using three different analytical methods. Results: Five potential tissue biomarkers of kidney cancer were identified and quantified using with high-resolution nuclear magnetic resonance spectroscopy. The contents of selected chemical elements in tissues was analyzed using inductively coupled plasma optical emission spectrometry. Eleven mass spectral features differentiating between kidney cancer and normal tissues were detected using silver-109 nanoparticle enhanced steel target laser desorption/ionization mass spectrometry. Conclusions: Our results, derived from the combination of ICP-OES, LDI MS and 1H NMR methods, suggest that tissue biomarkers identified herein appeared to have great potential for use in clinical prognosis and/or diagnosis of kidney cancer.Keywords
Funding Information
- Narodowe Centrum Nauki (2016/23/B/ST4/00062.)
- National Institutes of Health (1S10RR13878, 1S10RR026659)
- the National Science Foundation (NSF-MRI:DBI-1532078)
- M.J. Murdock Charitable Trust (2015066:MNL)
This publication has 50 references indexed in Scilit:
- Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalitiesImmunoTargets and Therapy, 2013
- Biomedical applications of sodium MRI in vivoJournal of Magnetic Resonance Imaging, 2013
- Targeting 20-HETE producing enzymes in cancer – rationale, pharmacology, and clinical potentialOncoTargets and Therapy, 2013
- Application of ex vivo 1H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastasesZeitschrift für Krebsforschung und Klinische Onkologie, 2012
- Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic LethalityScience Translational Medicine, 2011
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progressionNature, 2009
- Metabonomic profiling of renal cell carcinoma: High-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysisAnalytica Chimica Acta, 2008
- LIPID MAPS online tools for lipid researchNucleic Acids Research, 2007
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007
- LMSD: LIPID MAPS structure databaseNucleic Acids Research, 2006